Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Skin aging is largely due to differences in stiffness and elasticity between skin layers, leading to wrinkles.

Better hair care products are needed to protect against grooming and chemical damage.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Bergamot may improve heart health, skin conditions, and mood, but more research is needed to confirm these benefits.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Photobiomodulation may help with hair growth and wound healing, but research is inconsistent and needs better quality studies.

Mice with enhanced regeneration abilities may help develop new regenerative medicine therapies.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Women with high androgen levels may have more severe COVID-19 symptoms.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.